Multiparameter computational modeling of tumor invasion

Cancer Research

Volumn 69, Issue 10, 2009, Pages 4493-4501

  Bearer, Elaine L ^a,b   Lowengrub, John S ^c,d   Frieboes, Hermann B ^e   Chuang, Yao Li ^e   Jin, Fang ^c   Wise, Steven M ^c,j   Ferrari, Mauro ^f,g,h   Agus, David B ^k   Cristini, Vittorio ^e,f,g,i  

^a BROWN UNIVERSITY   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of California at Irvine   (United States)

^e University of Texas School of Health Information Sciences at Houston   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h Rice University   (United States)

ⁱ The University of Texas at Austin   (United States)

^j UNIVERSITY OF TENNESSEE   (United States)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; MORPHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

AUTOPSY; BRAIN NEOPLASMS; CELL DIVISION; CELL MOVEMENT; CELL SURVIVAL; COMPUTER SIMULATION; GLIOBLASTOMA; HUMANS; KINETICS; MATHEMATICS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEOPLASM INVASIVENESS; NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 66249101668     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3834     Document Type: Article

References (50)

1. Sanga S, et al. Mathematical modeling of cancer progression and response to chemotherapy. Expert Rev Anticancer Ther 2006;6:1361-1376
2. Sanga S, et al. Predictive oncology: a review of multidisciplinary, multiscale in silico modeling linking phenotype, morphology and growth. Neuroimage 2007;37:S120-34. (Pubitemid 47239436)
3. Araujo R, McElwain D. A history of the study of solid tumour growth: the contribution of mathematical modelling. Bull Math Biol 2004;66:1039-1091 (Pubitemid 39033599)
4. Hatzikirou H, Deutsch A, Schaller C, Simon M, Swanson K. Mathematical modeling of glioblastoma tumour development: a review. Math Models Methods Appl Sci 2005;15:1779-1794 (Pubitemid 41551045)
5. Byrne HM, Alarćon T, Owen MR, Webb SW, Maini PK. Modeling aspects of cancer dynamics: a review. Philos Trans R Soc A 2006;364:1563-1578
6. Roose T, Chapman SJ, Maini PK. Mathematical models of avascular tumor growth. SIAM Review 2007;49:179-208. (Pubitemid 46888016)
7. Anderson ARA, Quaranta V. Integrative mathematical oncology. Nat Rev Cancer 2008;8:227-244
8. Zheng X, Wise SM, Cristini V. Nonlinear simulation of tumor necrosis, neo-vascularization and tissue invasion via an adaptive finite-element/level-set method. Bull Math Biol 2005;67:211-259 (Pubitemid 40234527)
9. Cristini V, et al. Morphologic instability and cancer invasion. Clin Cancer Res 2005;11:6772-6779 (Pubitemid 41428730)
10. Frieboes HB, et al. An integrated computational/experimental model of tumor invasion. Cancer Res 2006;66:1597-1604 (Pubitemid 43259943)
11. Frieboes HB, et al. Computer simulation of glioma growth and morphology. Neuroimage 2007;37:S59-70.
12. Wise SM, Lowengrub JS, Frieboes HB, Cristini C. Three-dimensional multispecies nonlinear tumor growth. I. Model and numerical method. J Theor Biol 2008;253:524-543
13. Cristini V, Li X, Lowengrub JS, Wise SM. Nonlinear simulations of solid tumor growth using amixture model: invasion and branching. J Math Biol 2009;58:723-763
14. Cristini V, Lowengrub J, Nie Q. Nonlinear simulation of tumor growth. J Math Biol 2003;46:191-224. (Pubitemid 38355715)
15. Li,X, Cristini V, Nie Q, Lowengrub JS. Nonlinear three-dimensional simulation of solid tumor growth. Discrete Contin Dyn Syst B 2007;7:581-604.
16. Pennacchietti S, Michieli P, Galluzzo M, Giordano S, Comoglio P. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003;3:347-361 (Pubitemid 38340304)
17. Rubenstein JL, et al. Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2000;2:306-314
18. Kunkel P, et al. Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res 2001;61:6624-6628 (Pubitemid 32896475)
19. Bello L, et al. Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma. Clin Cancer Res 2004;10:4527-4537 (Pubitemid 38878897)
20. Madsen SJ, et al. Photodynamic therapy of newly implanted glioma cells in the rat brain. Lasers Surg Med 2006;38:540-548
21. Lamszus K, Kunkel P, Westphal M. Invasion as limitation to anti-angiogenic glioma therapy. Acta Neurochir Suppl 2003;88:169-177
22. Friedl P, Wolf K. Tumor cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003;3:362-374 (Pubitemid 37328856)
23. Debnath J, Brugge J. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 2005;5:675-688 (Pubitemid 41486361)
24. Maher EA, et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev 2001;15:1311-1333 (Pubitemid 32524640)
25. Benjamin R, Capparella J, Brown A. Classification of glioblastoma multiforme in adults by molecular genetics. Cancer J 2003;9:82-90.
26. Merlo A. Genes and pathways driving glioblastomas in humans and murine disease models. Neurosurg Rev 2003;26:145-158 (Pubitemid 36835031)
27. Lal A, et al. Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. Cancer Res 2002;62:3335-3339 (Pubitemid 34651373)
28. Nishikawa R, et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci U S A 1994;91:7727-7731 (Pubitemid 24238258)
29. Nagane M, Levitzki A, Gazit A, Cavenee WK, Huang HJS. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-X L and caspase-3-like proteases. Proc Natl Acad Sci U S A 1998;95:5724-5729 (Pubitemid 28224163)
30. Zhang L, Athale CA, Deisboeck TS. Development of a three-dimensional multiscale agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer. J Theor Biol 2007;244:96-107.
31. Stein AM, Demuth T, Mobley D, Berens M, Sander LM. A mathematical model of glioblastoma tumor spheroid invasion in a three-dimensional in vitro experiment. Biophys J 2007;92:356-365 (Pubitemid 46048443)
32. Athale CA, Deisboeck TS. The effects of EGF-receptor density on multiscale tumor growth patterns. J Theor Biol 2006;238:771-779 (Pubitemid 43175828)
33. Anderson ARA, Weaver AM, Cummings PT, Quaranta V. Tumor morphology and phenotypic evolution driven by selective presure from the microenvironment. Cell 2006;127:905-915
34. Tysnes BB, Mahesparan R. Biological mechanisms of glioma invasion and potential therapeutic targets. J Neurooncol 2001;53:129-147 (Pubitemid 33036822)
35. Ishii N, et al. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 1999;9:469-479 (Pubitemid 29316287)
36. Jensen RL. Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures. Neurosurg Focus 2006;20:E24.
37. Chaplain MAJ. Avascular growth, angiogenesis and vascular growth in solid tumours: the mathematical modelling of the stages of tumour development. Math Comput Model 1996;23:47-87. (Pubitemid 126686208)
38. Bartels U, et al. Vascularity and angiogenesis as predictors of growth in optic pathway/hypothalamic gliomas. J Neurosurg 2006;104:314-320
39. Preusser M, et al. Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: poor observer agreement limits clinical utility as prognostic factors: a translational research project of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Cancer 2006;107:162-170 (Pubitemid 43939043)
40. Macklin P, Lowengrub JS. Nonlinear simulation of the effect of microenvironment on tumor growth. J Theor Biol 2007;245:677-704. (Pubitemid 46454401)
41. Okada Y, et al. Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas. Cancer Res 2003;63:413-416 (Pubitemid 36152501)
42. Hu B, et al. Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2. Proc Natl Acad Sci U S A 2003;100:8904-8909 (Pubitemid 36899196)
43. Plate KH, Risau W. Angiogenesis in malignant gliomas. Glia 1995;15:339-347
44. Rong Y, Durden DL, Van Meir EG, Brat DJ. 'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 2006;65:529-539
45. Sierra A. Metastases and their microenvironments: linking pathogenesis and therapy. Drug Resist Updat 2005;8:247-257 (Pubitemid 41446966)
46. van Kempen LCLT, Ruiter DJ, van Muijen GNP, Coussens LM. The tumor microenvironment: a critical determinant of neoplastic evolution. Eur J Cell Biol 2003;82:539-548 (Pubitemid 38008835)
47. Sinek J, et al. Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation. J Math Biol 2009;58:485-510.
48. Jain RK. Normalizing tumor vasculature with antiangiogenic therapy: a new paradigm for combination therapy. Nat Med 2001;7:987-989 (Pubitemid 32937367)
49. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005;5:161-171 (Pubitemid 40314948)
50. Kenny PA, Lee GY, Bissell MJ. Targeting the tumor microenvironment. Front Biosci 2007;12:3468-3474